Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic neuropathies in the elderly: management update.

M C Riddle1

  • 1Division of Endocrinology/Diabetes/Clinical Nutrition, Oregon Health Sciences University, Portland.

Geriatrics
|September 1, 1990
PubMed
Summary

Diabetic neuropathy, a disabling nerve condition, may be prevented or reversed with improved blood sugar control. Painful symptoms can be managed with medication, while lifestyle changes help some patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to the Letter to the Editor: Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment.

The journal of prevention of Alzheimer's disease·2024
Same author

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023
Same author

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017
Same author

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic neuropathy is a frequent and debilitating complication of diabetes mellitus.
  • Its exact cause remains unknown, but its clinical features and progression are well-documented.

Purpose of the Study:

  • To review the clinical presentations, natural history, and therapeutic options for diabetic neuropathy.
  • To highlight the role of glycemic control in the prevention and management of this condition.

Main Methods:

  • Review of existing literature on diabetic neuropathy.
  • Analysis of clinical data regarding presentation, progression, and treatment outcomes.

Main Results:

  • Good glycemic control may prevent the onset of neuropathy and potentially reverse established cases.
  • Pharmacological interventions are primarily effective for managing neuropathic pain.
  • Lifestyle modifications, including alcohol avoidance and nerve entrapment treatment, offer adjunctive benefits.

Conclusions:

  • Diabetic neuropathy is a significant complication requiring proactive management.
  • Glycemic control is paramount for preventing and potentially reversing neuropathy.
  • Symptomatic and supportive therapies are crucial for improving patient quality of life.

Related Experiment Videos